136 related articles for article (PubMed ID: 2988025)
1. Combined modality treatment for stage III ovarian carcinoma.
Rizel S; Biran S; Anteby SO; Brufman G; Sulkes A; Milwidsky A; Weshler Z; Fuks Z
Radiother Oncol; 1985 Apr; 3(3):237-44. PubMed ID: 2988025
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma.
Fuks Z; Rizel S; Biran S
J Clin Oncol; 1988 Mar; 6(3):509-16. PubMed ID: 3127551
[TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
6. Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy.
Hainsworth JD; Malcolm A; Johnson DH; Burnett LS; Jones HW; Greco FA
Obstet Gynecol; 1983 May; 61(5):619-23. PubMed ID: 6403897
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
8. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma.
Baker TR; Piver MS; Hempling RE
Cancer; 1994 Jul; 74(2):656-63. PubMed ID: 8033045
[TBL] [Abstract][Full Text] [Related]
9. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
10. The sequential multiple modality treatment of ovarian cancer.
Dembo AJ
Radiother Oncol; 1985 Apr; 3(3):187-92. PubMed ID: 3923573
[No Abstract] [Full Text] [Related]
11. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
Rothenberg ML; Ozols RF; Glatstein E; Steinberg SM; Reed E; Young RC
J Clin Oncol; 1992 May; 10(5):727-34. PubMed ID: 1569445
[TBL] [Abstract][Full Text] [Related]
12. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma.
Rosen EM; Goldberg ID; Rose C; Come S; Goldstein M; Simon L; Botnick LE
Radiother Oncol; 1986 Nov; 7(3):223-31. PubMed ID: 3809585
[TBL] [Abstract][Full Text] [Related]
13. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma].
Albrecht M; Goepel E; Simon WE; Trams G
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):482-7. PubMed ID: 2993094
[TBL] [Abstract][Full Text] [Related]
14. The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute.
Lichter AS; Ozols RF; Myers CC; Ostechega Y; Young RC
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1225-31. PubMed ID: 3112047
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of 63 advanced ovarian carcinomas].
Liu LY; Hong WJ; Hou YJ; Yao ZH; Wu AR; Li L
Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):375-8. PubMed ID: 3452529
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; GĂ©rard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
17. Management of recurrent ovarian carcinoma.
Ang PT; Kavanagh J
Am J Clin Oncol; 1989 Jun; 12(3):269-72. PubMed ID: 2543208
[No Abstract] [Full Text] [Related]
18. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.
Piver MS; Lele SB; Marchetti DL; Baker TR; Tsukada Y; Emrich LJ
J Clin Oncol; 1988 Jun; 6(6):983-9. PubMed ID: 3373267
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
20. Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma.
Kuten A; Stein M; Steiner M; Rubinov R; Epelbaum R; Cohen Y
Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):273-9. PubMed ID: 3338949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]